Purchase Order N0023222P0003
- Not listed
- The Department of the Army Medical Command awarded Gen-Probe Incorporated, a medical diagnostics company, a $330,000.00 firm fixed price purchase order for the PANTHER INSTRUMENT SYSTEM. This contract is not set aside and is related to the Coronavirus COVID-19 national interest action. Gen-Probe Incorporated has previously provided a variety of medical testing systems and assays, including for infectious diseases, to federal agencies such as the Defense Health Agency, Department of Veterans...
- This federal contract award is for PANTHER EQUIPMENT AND TEST KITS, delivered by Gen-Probe Incorporated, a medical diagnostics company, to the U.S. Department of Defense's Medical Command. The $659,000.00 Firm Fixed Price Delivery Order contract has an ultimate completion date of September 30, 2020. Gen-Probe has held numerous federal contracts to provide medical diagnostic products and services, including molecular testing systems, assays, and supplies for detecting infectious diseases like...
- This federal contract award to Gen-Probe Incorporated, a medical diagnostics company, is for the delivery of PANTHER FUSION SARS-COV2 ASSAY PPR SOLUTION (test kits) and DNA/RNA ENZYME CARTRIDGE (reagent) kits in support of the COVID-19 response. The $1,800,000.00 firm fixed-price delivery order was issued by the Medical Command (MEDCOM) of the U.S. Department of the Army. The contract has no set-aside designation. Gen-Probe, a large specialized supplier in molecular diagnostics, has held...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call order awarded by the Defense Health Agency (DHA) to Gen-Probe Incorporated, a for-profit medical diagnostics company, for $56,000.00. The contract is for the PANTHER FUSION STANDARD SERVICE, a molecular diagnostic testing system and related products and services. Gen-Probe has held numerous contracts with defense and civilian agencies to supply testing kits, reagents, and equipment for detecting infectious diseases such as HIV,...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company that produces molecular diagnostic testing systems and assays. The contract is for the delivery of APTIMA SARS-CoV-2 tests to detect COVID-19, with a potential value of $745,185.00 and a completion date of March 31, 2023. The contract is part of the agency's efforts to procure necessary medical supplies related to the Coronavirus COVID-19 national interest...
- This federal contract was awarded by the Department of the Army Medical Command to Gen-Probe Incorporated, a medical diagnostics company, for the provision of nucleic acid reagents and associated PANTHER and TIGRIS instruments. The $223,801.32 firm-fixed-price purchase order does not have a set-aside designation. Gen-Probe has previously supplied a range of molecular diagnostic testing systems, assays, and COVID-19 related products to federal agencies including the Defense Health Agency,...
- This federal contract award is for a minimum guarantee delivery order with a firm fixed price of $456,519.00, issued by the Department of the Army Medical Command to Gen-Probe Incorporated, a medical diagnostics company. The award does not have a set-aside designation. Through this contract, Gen-Probe Incorporated will provide a variety of goods and services, including APTIMA combo assay test kits for chlamydia and gonorrhea, APTIMA HIV-1 and hepatitis C virus tests, PANTHER FUSION systems and...
- This is a firm fixed-price delivery order contract awarded by the Department of the Army Medical Command to Gen-Probe Incorporated, a medical diagnostics company, for PANTHER EQUIPMENT AND TEST KITS. The potential value of the contract is $539,000.00. There was no set-aside designation used for this award. Gen-Probe Incorporated has provided a variety of medical testing products and services to federal agencies in the past, including APTIMA assays for infectious diseases, PANTHER FUSION systems,...
- This is a firm fixed-price delivery order awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the APTIMA SARS-CoV-2 ASSAY, a 250-test COVID-19 test kit. The contract has an ultimate completion date of February 18, 2022 and a ceiling value of $320,542.72. The contract is not set-aside. Gen-Probe has held numerous federal contracts with defense and civilian agencies, primarily supplying testing kits, reagents, and equipment for infectious disease...
- The Department of the Army Medical Command awarded a firm-fixed-price purchase order to Gen-Probe Incorporated, a medical diagnostics company, for the PANTHER FUSION SYSTEM - LABORATORY TESTING FOR COVID-19. The award, with a potential value of $239,000.00, does not have a set-aside designation. The original solicitation requested virtual health equipment, including examination cameras, stethoscopes, headphones, webcams, and emergency response kits, for the telehealth department at Landstuhl...
This federal contract award, valued at $25,000.00, was issued by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the procurement of PANTHER COVID-19 testing supplies. The contract is a purchase order with a firm fixed price and does not have a set-aside designation. Gen-Probe Incorporated is a key supplier of molecular diagnostic testing systems, assays, and related products and services to various federal agencies, including the Department of Defense, Department of Veterans Affairs, and Department of the Army. The company has held numerous contracts to provide infectious disease testing capabilities, particularly during the COVID-19 pandemic, where it has supplied millions of dollars worth of SARS-CoV-2 assays and testing equipment. This specific award is part of the broader federal response to the Coronavirus national interest action.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.0k | 12/28/21 |